Why Obesity Is More Than Calories

Added: 2026-05-26

[00:00:00]human, and you'll be fine. I love that.

[00:00:02]I love eating your greens and going to the gym, okay? Um but, the unfortunate reality is that here in the United States, uh it depends on what database you look at, but obesity rates are estimated to be 40 to 70%, okay? Whether you Depending on what BMI cutoff you're using, okay? BMI's not perfect, but it is what it is. And so, the thing is is that well, eating greens and going to the gym are not working for us as a society. And we could talk about how we don't have real food anymore, we have food deserts, we have this nutri- calorically dense, but nutritionally poor food. Uh I'll tell you the most disturbing thing I see as a surgeon is I'll see a patient come in the door, and they're morbidly obese. They're a large individual, but I have to do surgery on them, but the connective tissue, the stuff that's made up of protein that makes them them, that literally holds them together, is paper paper thin because they're eating an incredible amount of calories, they're gaining fat, but they don't have any protein in their diet. And that's not something that's rare. I see that on a daily basis. And so, the truth is is that, you know, we're talking about this from the angle of biohackers and people that are super engaged in our health, but the truth is is that this is going to be able to be used to help our population at large, and, you know, ultimately, hopefully, avoid a lot of the terrible disease states that we're seeing overwhelm the medical system right now. How big is the peptide industry right now?

[00:01:20]If we look at the top four large language models companies, all right?

[00:01:23]So, all the heavy hitters, and how much revenue they're generating, it's estimated between be between 58 billion up to maybe 62 billion. Yet, the income and the revenue from just semaglutide and tirzepatide alone is going to be over 55 billion this year. And so, what we have is peptides without even considering all of this happening in the research space or the research use only space, without even considering the peptides that uh we'll see come from compounding pharmacies, we're already approaching in with what we're seeing in AI as far as revenue goes. That is the demand that we're seeing in the marketplace.

[00:02:02]I run multiple companies